Cellebrite DI Ltd
NASDAQ:CLBT
Cellebrite DI Ltd
NASDAQ:CLBT
Price:
13.255
USD
-3.81%
Market Closed
Market Cap:
$3.2B
Balance Sheet
Balance Sheet Decomposition
Cellebrite DI Ltd
Cellebrite DI Ltd
Balance Sheet Decomposition is not available for
Cellebrite DI Ltd
Cellebrite DI Ltd
Balance Sheet
Cellebrite DI Ltd
Cellebrite DI Ltd
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
77
|
129
|
146
|
88
|
190
|
192
|
124
|
|
| Cash Equivalents |
77
|
129
|
146
|
88
|
190
|
192
|
124
|
|
| Short-Term Investments |
124
|
109
|
36
|
51
|
113
|
256
|
313
|
|
| Total Receivables |
47
|
70
|
73
|
86
|
83
|
90
|
112
|
|
| Accounts Receivables |
47
|
70
|
73
|
86
|
83
|
90
|
112
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
4
|
5
|
7
|
10
|
10
|
9
|
8
|
|
| Other Current Assets |
11
|
12
|
12
|
61
|
26
|
22
|
20
|
|
| Total Current Assets |
262
|
324
|
273
|
296
|
422
|
568
|
576
|
|
| PP&E Net |
15
|
16
|
17
|
33
|
30
|
28
|
39
|
|
| PP&E Gross |
15
|
16
|
17
|
33
|
30
|
28
|
0
|
|
| Accumulated Depreciation |
12
|
17
|
21
|
27
|
33
|
40
|
0
|
|
| Intangible Assets |
0
|
7
|
11
|
11
|
11
|
11
|
81
|
|
| Goodwill |
0
|
10
|
27
|
27
|
27
|
29
|
120
|
|
| Long-Term Investments |
0
|
0
|
0
|
22
|
29
|
37
|
98
|
|
| Other Long-Term Assets |
4
|
8
|
12
|
14
|
14
|
19
|
25
|
|
| Other Assets |
0
|
10
|
27
|
27
|
27
|
29
|
120
|
|
| Total Assets |
280
N/A
|
364
+30%
|
340
-7%
|
403
+19%
|
533
+32%
|
691
+30%
|
939
+36%
|
|
| Liabilities | ||||||||
| Accounts Payable |
5
|
5
|
10
|
5
|
53
|
74
|
88
|
|
| Accrued Liabilities |
22
|
39
|
43
|
45
|
45
|
61
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
72
|
116
|
135
|
158
|
200
|
224
|
278
|
|
| Total Current Liabilities |
99
|
159
|
187
|
208
|
254
|
296
|
370
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
21
|
40
|
227
|
122
|
245
|
59
|
85
|
|
| Total Liabilities |
120
N/A
|
199
+66%
|
413
+107%
|
329
-20%
|
499
+51%
|
355
-29%
|
455
+28%
|
|
| Equity | ||||||||
| Common Stock |
101
|
101
|
0
|
0
|
0
|
2
|
0
|
|
| Retained Earnings |
33
|
28
|
78
|
199
|
118
|
165
|
87
|
|
| Additional Paid In Capital |
26
|
34
|
153
|
126
|
85
|
499
|
569
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
1
|
1
|
0
|
1
|
0
|
2
|
|
| Total Equity |
160
N/A
|
165
+3%
|
73
N/A
|
74
N/A
|
34
-54%
|
336
+882%
|
484
+44%
|
|
| Total Liabilities & Equity |
280
N/A
|
364
+30%
|
340
-7%
|
403
+19%
|
533
+32%
|
691
+30%
|
939
+36%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
189
|
189
|
189
|
193
|
203
|
235
|
244
|
|
Switch to:
Switch to:
See Also
Discover More
